Farhangdoost et al. recently demonstrated that CRISPR/Cas9-generated knockout of NSD1 as well as a mutation of NSD1 in HNSCC cell lines may downregulate several gene programs including mTORC1 signaling [11]. This evidence concerns the gene NSD1 and head and neck squamous cell carcinoma.